Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Milestone Scientific (MLSS) over the last 10 years, with Q3 2025 value amounting to $363082.0.

  • Milestone Scientific's Share-based Compensation fell 2499.51% to $363082.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1220.29%. This contributed to the annual value of $1.3 million for FY2024, which is 833.44% down from last year.
  • As of Q3 2025, Milestone Scientific's Share-based Compensation stood at $363082.0, which was down 2499.51% from $159678.0 recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's Share-based Compensation ranged from a high of $484078.0 in Q3 2024 and a low of $113507.0 during Q1 2021
  • Moreover, its 5-year median value for Share-based Compensation was $330788.0 (2025), whereas its average is $313490.2.
  • In the last 5 years, Milestone Scientific's Share-based Compensation skyrocketed by 94363.31% in 2021 and then plummeted by 4863.39% in 2024.
  • Quarter analysis of 5 years shows Milestone Scientific's Share-based Compensation stood at $291639.0 in 2021, then soared by 37.66% to $401464.0 in 2022, then decreased by 11.82% to $353999.0 in 2023, then dropped by 4.0% to $339852.0 in 2024, then grew by 6.84% to $363082.0 in 2025.
  • Its last three reported values are $363082.0 in Q3 2025, $159678.0 for Q2 2025, and $330788.0 during Q1 2025.